Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression.

Li Y, Zhou J, Zhuo Q, Zhang J, Xie J, Han S, Zhao S.

Cancer Manag Res. 2019 Jul 29;11:7123-7134. doi: 10.2147/CMAR.S210568. eCollection 2019.

2.

Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts.

Li Y, Yang Y, Xiong A, Wu X, Xie J, Han S, Zhao S.

Front Immunol. 2017 Jun 1;8:607. doi: 10.3389/fimmu.2017.00607. eCollection 2017.

3.

Exosomes Isolated from Ascites of T-Cell Lymphoma-Bearing Mice Expressing Surface CD24 and HSP-90 Induce a Tumor-Specific Immune Response.

Menay F, Herschlik L, De Toro J, Cocozza F, Tsacalian R, Gravisaco MJ, Di Sciullo MP, Vendrell A, Waldner CI, Mongini C.

Front Immunol. 2017 Mar 16;8:286. doi: 10.3389/fimmu.2017.00286. eCollection 2017.

4.

Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.

Popēna I, Ābols A, Saulīte L, Pleiko K, Zandberga E, Jēkabsons K, Endzeliņš E, Llorente A, Linē A, Riekstiņa U.

Cell Commun Signal. 2018 Apr 24;16(1):17. doi: 10.1186/s12964-018-0229-y.

5.

Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.

Beez CM, Haag M, Klein O, Van Linthout S, Sittinger M, Seifert M.

J Nanobiotechnology. 2019 May 27;17(1):72. doi: 10.1186/s12951-019-0504-0.

6.

Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells.

Dusoswa SA, Horrevorts SK, Ambrosini M, Kalay H, Paauw NJ, Nieuwland R, Pegtel MD, Würdinger T, Van Kooyk Y, Garcia-Vallejo JJ.

J Extracell Vesicles. 2019 Aug 9;8(1):1648995. doi: 10.1080/20013078.2019.1648995. eCollection 2019.

7.

Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.

Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F, Ochiya T.

Nat Commun. 2017 Mar 6;8:14470. doi: 10.1038/ncomms14470.

8.

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, André S, Gabius HJ, Rancourt C, Connor J, Paulson JC, Patankar MS.

Mol Cancer. 2010 May 24;9:118. doi: 10.1186/1476-4598-9-118.

10.

Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis.

Greisen SR, Yan Y, Hansen AS, Venø MT, Nyengaard JR, Moestrup SK, Hvid M, Freeman GJ, Kjems J, Deleuran B.

Front Immunol. 2017 Jul 24;8:851. doi: 10.3389/fimmu.2017.00851. eCollection 2017.

11.

Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.

Yamamoto CM, Oakes ML, Murakami T, Muto MG, Berkowitz RS, Ng SW.

J Ovarian Res. 2018 Mar 2;11(1):20. doi: 10.1186/s13048-018-0391-2.

12.

Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.

Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL.

Clin Cancer Res. 1996 Jan;2(1):161-73.

13.

Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

Ikehara Y, Ikehara SK, Paulson JC.

J Biol Chem. 2004 Oct 8;279(41):43117-25. Epub 2004 Aug 3.

14.

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.

Ricklefs FL, Alayo Q, Krenzlin H, Mahmoud AB, Speranza MC, Nakashima H, Hayes JL, Lee K, Balaj L, Passaro C, Rooj AK, Krasemann S, Carter BS, Chen CC, Steed T, Treiber J, Rodig S, Yang K, Nakano I, Lee H, Weissleder R, Breakefield XO, Godlewski J, Westphal M, Lamszus K, Freeman GJ, Bronisz A, Lawler SE, Chiocca EA.

Sci Adv. 2018 Mar 7;4(3):eaar2766. doi: 10.1126/sciadv.aar2766. eCollection 2018 Mar.

15.

Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).

Fossati M, Buzzonetti A, Monego G, Catzola V, Scambia G, Fattorossi A, Battaglia A.

Gynecol Oncol. 2015 Aug;138(2):343-51. doi: 10.1016/j.ygyno.2015.06.003. Epub 2015 Jun 3.

PMID:
26049121
16.

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.

Bukowski RM, Rayman P, Uzzo R, Bloom T, Sandstrom K, Peereboom D, Olencki T, Budd GT, McLain D, Elson P, Novick A, Finke JH.

Clin Cancer Res. 1998 Oct;4(10):2337-47.

17.

Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer.

Zhao J, Schlößer HA, Wang Z, Qin J, Li J, Popp F, Popp MC, Alakus H, Chon SH, Hansen HP, Neiss WF, Jauch KW, Bruns CJ, Zhao Y.

Cancers (Basel). 2019 Jun 22;11(6). pii: E874. doi: 10.3390/cancers11060874.

18.

A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Kaur S, Elkahloun AG, Singh SP, Arakelyan A, Roberts DD.

J Cell Commun Signal. 2018 Mar;12(1):157-170. doi: 10.1007/s12079-017-0428-0. Epub 2017 Nov 29.

19.

Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.

Grange C, Tapparo M, Tritta S, Deregibus MC, Battaglia A, Gontero P, Frea B, Camussi G.

BMC Cancer. 2015 Dec 24;15:1009. doi: 10.1186/s12885-015-2025-z.

20.

Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma.

Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, Wu K.

J Surg Res. 2015 Mar;194(1):107-13. doi: 10.1016/j.jss.2014.09.035. Epub 2014 Oct 2.

PMID:
25450598

Supplemental Content

Support Center